Skip to content

Advertisement

  • Research note
  • Open Access

Diurnal variation of NMDA receptor expression in the rat cerebral cortex is associated with traumatic brain injury damage

BMC Research Notes201811:150

https://doi.org/10.1186/s13104-018-3258-0

  • Received: 8 December 2017
  • Accepted: 14 February 2018
  • Published:

Abstract

Objective

Data from our laboratory suggest that recovery from a traumatic brain injury depends on the time of day at which it occurred. In this study, we examined whether traumatic brain injury -induced damage is related to circadian variation in N‐methyl‐d‐aspartate receptor expression in rat cortex.

Results

We confirmed that traumatic brain injury recovery depended on the time of day at which the damage occurred. We also found that motor cortex N‐methyl‐d‐aspartate receptor subunit NR1 expression exhibited diurnal variation in both control and traumatic brain injury-subjected rats. However, this rhythm is more pronounced in traumatic brain injury—subjected rats, with minimum expression in those injured during nighttime hours. These findings suggest that traumatic brain injury occurrence times should be considered in future clinical studies and when designing neuroprotective strategies for patients.

Keywords

  • Excitotoxicity
  • Circadian rhythm
  • Glutamate receptor

Introduction

Traumatic brain injuries (TBIs) are among the most important contemporary health problems. TBIs are responsible for longer periods of disability than any other cause [1].

The initial damage from a TBI range from contusion to skull fracture, hemorrhage, and diffuse axonal injury. The TBI then triggers secondary injuries that are mainly mediated by excitotoxicity resulting from substantial neuronal Ca2+ entry. This Ca2+ entry in turn results from glutamate binding to N‐methyl‐d‐aspartate receptors (NMDARs), which contribute to several dysfunctions, such as hypoperfusion [2], edema [3, 4], excitotoxicity [5], and cognitive deficits [6].

NMDARs are heteromers composed of two subunits types NR1 and NR2 [7, 8]. The NR1 subunits play the main functional role and are involved in apoptosis following injuries like ischemia or TBI [9].

We previously showed that TBI-induced damage depends on the time of day at which the TBI occurs [10, 11]. This may arise from temporal variation in NMDAR expression. Although several articles describe diurnal variations for numerous receptors [12], very few exist for NMDARs, and most of them in suprachiasmatic nuclei [13, 14], but there are reports in other tissues like hippocampus [15].

We are interested in the motor cortex because it is involved in movement initiation and the suppression of unwanted movements [16]. However, there is no data regarding diurnal variations in NMDAR expression within this structure. If such variations exist, then they might be associated with variations in TBI-triggered excitotoxicity.

Here, we explore the possible association between diurnal variation in rat cerebral cortex NMDAR expression and behavioral recovery from TBIs induced at different hours.

Main text

Methods

Subjects

Male Wistar rats (250–300 g) were maintained under controlled temperature and dark–light cycle (12:12 h; lights on at 08:00 h) with food and water ad libitum. All animal experiments were approved by the local ethics committee (protocol 128-2009, Facultad de Medicina, UNAM) and conducted according to official guidelines (NOM-062-ZOO-1999).

TBI

Rats were anesthetized with chloral hydrate [Riedel–de Haen, Germany] (350 mg/kg, i.p.) and subjected to TBIs with a modified closed-skull weight-drop injury protocol [17, 18]. Severe TBIs were induced on the exposed skull over the motor cortex (L:1.4, A:2) located with a stereotaxic device as previously described [11]. It consists of a pneumatic piston, which can be controlled in terms of the firing pressure and distance, therefore the magnitude of the impact is perfectly controlled. Previous trials in our laboratory allow us to establish with precision that our damage is similar in each subject. This model also reproduces focal damage [19], epidural hematoma and skull fracture (with or without brain damage) [20] and acute post-traumatic hemorrhage associated with severe TBIs in humans [21]. Furthermore, MRI studies have shown that this model accurately represents the clinical conditions that occur in closed skull lesions in humans, such as those occurring in falls or motor vehicle accidents [22].

Neurological behavior

We used a 21-point behavioral-neurological scale [23] to evaluate neurological status in control rats and TBI-subjected rats 24 h after model induction. Although this scale was designed to evaluate damage caused by cerebral ischemia, many pathophysiological pathways are reportedly activated in both forms of brain damage [24], and we have previously used this scale to investigate TBI-induced neurological damage [10, 11, 25, 26].

Diurnal variations

Control rats were subjected to neurobehavioral analysis before being deeply anesthetized with sodium pentobarbital [Pisa, México] (40 mg/kg, i.p.) and euthanized at different hours of the day (01:00, 05:00, 09:00, 13:00, 17:00, or 21:00 h) that we have previously used to analyze the diurnal variations of other receptors [11]. The motor cortex was dissected from each rat and stored at − 70 °C (Fig. 1).
Fig. 1
Fig. 1

Experimental design

We used another group of rats to analyze the effects of TBI on behavioral variables. These rats were anesthetized with chloral hydrate and subjected to TBI at different times (01:00, 05:00, 09:00, 13:00, 17:00, or 21:00 h). We quantified mortality immediately after TBI induction. After 24 h, we measured bodyweights and used a neurobehavioral scale to assess motor skill behaviors. The rats were deeply anesthetized with sodium pentobarbital and euthanized. The ipsilateral motor cortex was dissected and stored at − 70 °C (Fig. 1).

Western blotting

The motor cortex was homogenized with phosphate-buffered saline (PBS) [JT Baker, México] and protease inhibitors [Sigma-Aldrich, USA], and centrifuged (600g, 10 min, 4 °C). The supernatant was centrifuged again (39,000g, 15 min, 4 °C). Electrophoresis through a 7% analytical sodium dodecyl sulfate [JT Baker, México] -polyacrylamide [Merck, México] gel was performed. The resuspended tissue homogenates (60 μg of protein) were mixed with Laemmli buffer (1:1 ratio), heated (95 °C, 5 min) and loaded into a 0.75-mm-thick gel. The samples were electrophoresed (150 V, 2 h), and electroblotted (100 V, 1 h, 4 °C) onto a nitrocellulose membrane (GE Healthcare Life Sciences, Chicago, IL). The membrane was stained with Ponceau S [Sigma-Aldrich, USA], and cut into two pieces. One piece was used to analyze the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels, and the other to analyze NR1 levels. The membrane was washed and incubated with 3% PBS-Tween, 10 or 20% nonfat dry milk, and 2 or 6% normal goat serum [Sigma-Aldrich, USA], for 30 min at room temperature. It was then incubated with anti-GAPDH (1:2000; Santa Cruz Biotechnology [sc166545], Dallas, TX) or anti-NR1 (1:1000; Abcam [ab17345], Cambridge, UK) antibodies overnight at 4 °C. The blot was thrice washed with PBS-Tween for 5 min, incubated for 1 h at room temperature with goat anti-rabbit immunoglobulin G horseradish peroxidase conjugate [Sigma-Aldrich, USA] (1:2000), and developed with diaminobenzidine [Sigma-Aldrich, USA] (0.5 mg/mL in PBS plus 0.009% H2O2). The band density was analyzed with Quantity One software (Bio-Rad Laboratories, Hercules, CA).

Statistical analysis

The results are reported as mean values ± standard errors of the mean (SEM). Statistical significance was assessed with two-way analysis of variance and Tukey’s multiple comparisons corrections for bodyweights and NR1 expression, Kruskal–Wallis and Mann–Whitney U tests for neurological scores, and Chi square tests for survival data. Statistical significance was defined as P < 0.05.

Results

Figure 2a shows that 24 h after the induction of the TBI, bodyweight losses significantly varied depending on the TBI induction time (F1,107 = 287.0, P < 0.0001).
Fig. 2
Fig. 2

Effects of TBI induction time on bodyweight, neurobehavioral damage, and survival. a Bars represent the means ± standard errors of bodyweight losses 24 h after TBI induction at different times of day; *P < 0.05 vs control group at the same hour, #P < 0.05 vs TBI group at 21:00 h. b Bars represent the means ± standard errors of neurobehavioral test scores obtained 24 h after TBI induction at different times of day; *P < 0.05 vs control group at the same hour, #P < 0.05 vs TBI group at 01:00 and 21:00 h. c Bars represent the survival rates observed over a 24-h period following TBI induction at different times of day. n = 7–10 per timepoint in each group

Figure 2b shows the neurobehavioral scale findings. The rats with TBIs induced during daytime hours had lower scores than did those with TBIs induced at night (Kruskal–Wallis = 64.52, P < 0.0001).

Finally, Fig. 2c shows the survival rates following TBIs induced at different times. The survival rate was 100% for TBIs induced at 01:00 h but 71% for those induced at 13:00 h (\(\upchi^{ 2 }_5 = 3. 6 2 8\), P = 0.6041). TBIs induced during daytime hours tended to cause greater damage than those induced at night did.

Figure 3 shows the observed expression of NMDAR subunit NR1 in the motor cortex. Figure 3a includes the results for all control and TBI-subjected rats. We found that TBIs induced a significant reduction of NMDAR expression in the motor cortex (t104 = 2.130, P = 0.0356). Nevertheless, this reduction depended on the TBI induction time. We found significant effects of experimental group (F1,94 = 10.88, P = 0.0014), TBI induction time (F5,94 = 10.21, P < 0.0001), and the two factors’ interaction (F5,94 = 2.540, P = 0.0334) (Fig. 3b, c). In control rats, we found that NR1 expression was greater at 09:00 and 13:00 h than at 21:00 h, whereas in TBI-subjected rats, NR1 expression was greater at 13:00 h than at 01:00, 09:00, and 21:00 h. Notably, TBIs induced at 01:00 h or 09:00 h reduced NR1 expression, but those induced at other times did not.
Fig. 3
Fig. 3

Effects of TBI and TBI induction time on NMDAR subunit NR1 expression in the rat cerebral cortex. a Data considering all the controls as a single group and all the experimental ones as another group. Bars represent means ± standard errors. *P < 0.05 vs control. b Representative Western immunoblotting of NR1 and GAPDH in motor cortex. c Data considering TBI induction time. Bars represent means ± standard errors. *P < 0.05 vs control group at the same hour; $P < 0.05 vs control group at 21:00 h; #P < 0.05 vs TBI group at 01:00 and 21:00 h. n = 7–9 per timepoint in each group

Discussion

TBIs are a major health problem and affect millions of people worldwide every year. They are associated with short- and long-term damage in several domains, including physical, cognitive, metabolic, and behavioral problems, which depend on the severity of the damage [27, 28].

TBIs induce abnormal homeostasis in areas of secondary damage. The influx of glutamate into the extracellular space is immediate and can last several minutes. This produces excessive NMDAR activation, which in turn produces excessive and uncontrolled entry of Na+ and Ca2+ into neurons [2830]. This Ca2+ influx interferes with mitochondrial oxidative phosphorylation and produces oxidative stress and apoptosis. This effect is amplified by neuronal hyperexcitability, which exacerbates glutamate release and produces a vicious circle involving generalized excitotoxicity [3136].

The excessive glutamate release causes astrocytes to recapture glutamate via the glutamate transporter GLT-1 [37], but persistently high extracellular glutamate concentrations can cause down-regulated of GLT1 and intracellular Na+ overload reverses glutamate transport. This causes glutamate efflux from the astrocytes, increasing excitotoxic damage [38, 39].

Moreover, NMDAR-mediated Ca2+ loading is more neurotoxic than equivalent Ca2+ loading mediated by other mechanisms [40]. Hardingham [41] suggests that neuronal responses by NMDA activation follow a bell-shaped curve in which excessively high and excessively low activity are both potentially harmful.

In this study, we hypothesized that the dependence of post-TBI behavioral recovery on TBI induction time is related to diurnal variation in rat motor cortex NMDAR expression. Our results support our initial hypothesis, we found that a TBI induced deterioration in an animal’s general condition. This manifested as decreased bodyweight, as reported by other authors [42, 43]. We also verified that post-TBI deterioration is observable on a neurobehavioral scale. This finding and the survival rates data corroborate our previous findings that showed that post-TBI recovery depends on the time of day at which the TBI occurs. This time-dependent recovery must respond to some rhythmic event that modulates the post-TBI damage. We proposed that this rhythmic event could be diurnal variations in the glutamatergic system. Given that excitotoxicity depends on NMDAR activation, we evaluated NMDAR expression in the area of damage. We propose that a greater expression of NMDAR produces greater influx of Ca2+ and therefore greater excitotoxicity, the opposite should happen in the hours with low expression levels and therefore should be less post-TBI damage. We therefore analyzed the expression of the NR1 subunit since, as indicated above, it is essential in the functioning of the NMDAR [7, 8, 44].

Several authors have shown that after a traumatic event there are changes in the expression of NMDAR, these effects were manifested from the first minutes until a week later and in various regions such as frontoparietal cortex and hippocampus, the expression also varies depending on the area of impact (decrease) or penumbra (increase) [45, 46].

With respect to the NR1 subunit, some authors found no variation in cortex and hippocampus between 1 and 7 days post-TBI [7, 8, 47] while others only saw a transient change in the hippocampus [48].

We found that the effect of TBI on NR1 expression depended on the TBI induction time. Moreover, our data show that the extent of TBI-induced damage also depended on the TBI induction time. TBIs caused less damage if they occurred during nighttime hours. Such nighttime TBIs were associated with decreased NMDAR expression and lower extracellular glutamate levels in the motor cortex as reported by Dash [49], which support Hardingham’s [41] proposal.

Numerous animal studies have shown that NMDAR antagonists can mitigate TBI-induced damage. However, clinical trials have found that such drugs have no benefits and even have detrimental effects [50]. Several authors have discussed the causes of these failures in humans and have suggested that they include trial design, human population heterogeneity, and inadequate dose ranges [51, 52]. We believe that another factor worth considering is the TBI occurrence time, since NMDAR expression depends on this variable.

Limitations

A TBI induces behavioral damage.

The extent of TBI-induced damage depends on the time of day the TBI is induced.

NMDAR activation-induced excitotoxicity is a primary mechanism of TBI damage.

NMDAR—subunit NR1 expression in cerebral cortex depends on the time of day the TBI is induced.

The minimal expression of NMDA—subunit NR1 is associated with a lesser damage caused by TBI.

The diurnal variation of NMDAR functionality in cerebral cortex has not been analyzed.

Abbreviations

GAPDH: 

glyceraldehyde 3-phosphate dehydrogenase

NMDAR: 

N‐methyl‐d‐aspartate receptor

PBS: 

phosphate-buffered saline

TBI: 

traumatic brain injury

Declarations

Authors’ contributions

FE-R and LN conceived and designed the experiments; FE-R and JM-G performed the in vivo experiments; FE-R and MM-V performed the western blot analysis. EC-U analyzed the data; FE-R and LN wrote the paper. All authors read and approved the final manuscript.

Acknowledgements

The data presented herein are part of F.E.-R.’s Ph.D. thesis at Posgrado en Ciencias Biológicas, UNAM. We thank Francisco Estrada Bernal for editing the manuscript.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

Data and further information about methods section are available from the corresponding author.

Consent to publish

Not applicable.

Ethics approval and consent to participate

All animal experiments were approved by the local ethics committee (protocol 128-2009, Facultad de Medicina, Universidad Nacional Autónoma de México) and conducted according to its guidelines. The experimental protocols followed the Norma Official Mexicana guidelines for the use and care of laboratory animals (NOM-062-ZOO-1999) and the disposal of biological residues (NOM-087-ECOL-1995).

Funding

This work was supported by PAPIIT grants IG201014 and IN223417, and CONACYT Grant 152510.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
(2)
Programa de Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de México, Mexico City, Mexico
(3)
Laboratorio de Neurociencias, Instituto Nacional de Pediatria, Mexico City, Mexico

References

  1. Maas AIR, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728–41.View ArticlePubMedGoogle Scholar
  2. Armstead WV. Age dependent NMDA contribution to impaired hypotensive cerebral hemodynamics following brain injury. Brain Res Dev Brain Res. 2002;139:19–28.View ArticlePubMedGoogle Scholar
  3. Okiyama K, Smith DH, White WF, Richter K, McIntosh TK. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat. J Neurotrauma. 1997;14:211–22.View ArticlePubMedGoogle Scholar
  4. Bauer R, Walter B, Fritz H, Zwiener U. Ontogenetic aspects of traumatic brain edema-facts and suggestions. Exp Toxicol Pathol. 1999;51:143–50.View ArticlePubMedGoogle Scholar
  5. Obrenovitch TP, Urenjak J. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury? J Neurotrauma. 1997;14:677–98.View ArticlePubMedGoogle Scholar
  6. Smith DH, Okiyama K, Thomas MJ, McIntosh TK. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci. 1993;13:5383–92.PubMedGoogle Scholar
  7. Osteen CL, Giza CC, Hovda DA. Injury-induced alterations in N-methyl-d-aspartate receptor subunit composition contribute to prolonged 45 calcium accumulation following lateral fluid percussion. Neuroscience. 2004;128:305–22.View ArticlePubMedGoogle Scholar
  8. Giza CC, Maria NS, Hovda DA. N-methyl-d-aspartate receptor subunit changes after traumatic injury to the developing brain. J Neurotrauma. 2006;6:950–61.View ArticleGoogle Scholar
  9. Liu Z, Zhao W, Xu T, Pei D, Peng Y. Alterations of NMDA receptor subnunits NR1, NR2A and NR2B mRNA expression and their relationships to apoptosis following transient forebrain ischemia. Brain Res. 2010;136:133–9.View ArticleGoogle Scholar
  10. Martinez-Vargas M, González-Rivera R, Soto-Núñez M, Cisneros-Martinez M, Huerta-Saquero A, Morales-Gomez J, Molina-Guarneros J, Navarro L. Recovery after a traumatic brain injury depends on diurnal variations, Effect of cystatin C. Neurosci Lett. 2006;400:21–4.View ArticlePubMedGoogle Scholar
  11. Martinez-Vargas M, Morales-Gomez J, Gonzalez-Rivera R, Hernandez-Enriquez C, Perez-Arredondo A, Estrada-Rojo F, Navarro L. Does the neuroprotective role of anandamide display diurnal variations? Int J Mol Sci. 2013;14:23341–55.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Wirz-Justice A. Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol. 1987;29(3):219–59.View ArticlePubMedGoogle Scholar
  13. Ishida N, Matsui M, Mitsui Y, Mishina M. Circadian expression of NMDA receptor mRNAs, epsilon 3 and zeta 1, in the suprachiasmatic nucleus of rat brain. Neurosci Lett. 1994;166(2):211–5.View ArticlePubMedGoogle Scholar
  14. Bendová Z, Sumová A, Mikkelsen JD. Circadian and developmental regulation of N-methyl-d-aspartate-receptor 1 mRNA splice variants and N-methyl-d-aspartate-receptor 3 subunit expression within the rat suprachiasmatic nucleus. Neuroscience. 2009;159(2):599–609.View ArticlePubMedGoogle Scholar
  15. Vilches N, Spichiger C, Mendez N, Abarzua-Catalan L, Galdames HA, et al. Gestational chronodisruption impairs hippocampal expression of NMDA receptor subunits Grin1b/Grin3a and spatial memory in the adult offspring. PLoS ONE. 2014;9(3):e91313.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Ebbesen CL, Brecht M. Motor cortex-to act or no to act? Nat Rev. 2017;18(11):694–705.View ArticleGoogle Scholar
  17. Shapira Y, Shohami E, Sidi A, Soffer D, Freeman S, Cotev S. Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit Care Med. 1988;16:258–65.View ArticlePubMedGoogle Scholar
  18. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E. An experimental model of closed head injury in mice: pathophysiology, histophathology, and cognitive déficits. J Neurotrauma. 1996;13:557–68.View ArticlePubMedGoogle Scholar
  19. Albert-Weissenberger C, Sirén A. Experimental traumatic brain injury. Exp Transl Stroke Med. 2010;2:16.View ArticlePubMedPubMed CentralGoogle Scholar
  20. LaPlaca MC, Simon CM, Prado GR, Cullen DK. CNS injury biomechanics and experimental models. Prog Brain Res. 2007;161:13–26.View ArticlePubMedGoogle Scholar
  21. Flierl MA, Stahel PF, Beauchamp KM, Morgan SJ, Smith WR, Shohami E. Mouse closed head injury model induced by a weight-drop device. Nat Protoc. 2009;4:1328–37.View ArticlePubMedGoogle Scholar
  22. Xiong Y, Mahmood A, Chopp M. Animal models of traumatic brain injury. Nat Rev Neurosci. 2013;2:128–42.View ArticleGoogle Scholar
  23. Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA. Functional assessments in mice and rats after focal stroke. Neuropharmacology. 2000;39:806–16.View ArticlePubMedGoogle Scholar
  24. Leker RR, Shohami E. Cerebral ischemia and trauma different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev. 2002;39:55–73.View ArticlePubMedGoogle Scholar
  25. Martinez-Vargas M, Estrada-Rojo F, Tabla-Ramon E, Navarro-Argüelles H, Ortiz-Lailzon N, Hernandez-Chavez A, Solis B, Martinez-Tapia R, Perez-Arredondo A, Morales-Gomez J, Gonzalez-Rivera R, Nava-Talavera K, Navarro L. Sleep deprivation has a neuroprotective role in a traumatic brain injury on the rat. Neurosci Lett. 2012;529:118–22.View ArticlePubMedGoogle Scholar
  26. Martinez-Vargas M, Soto-Nuñez M, Tabla-Ramon E, Solis B, Gonzalez-Rivera R, Perez-Arredondo A, Estrada-Rojo F, Castell A, Molina-Guarneros J, Navarro L. Cystatin C has a dual role in post-traumatic brain injury recovery. Int J Mol Sci. 2014;15:5807–20.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Waxweiler RJ, Thurman D, Sniezek J, Sosin D, O’Neil J. Monitoring the impact of traumatic brain injury: a review and update. J Neurotrauma. 1995;12:509–16.View ArticlePubMedGoogle Scholar
  28. Albensi BC. Models of brain injury and alterations in synaptic plasticity. J Neurosci Res. 2001;65:279–83.View ArticlePubMedGoogle Scholar
  29. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244:798–800.View ArticlePubMedGoogle Scholar
  30. Graham DI, McIntosh TK, Maxwell WL, Nicoll JA. Recent advances in neurotrauma. J Neuropathol Exp Neurol. 2000;59(8):641–51.View ArticlePubMedGoogle Scholar
  31. Yakovlev AG, Ota K, Wang G, Movsesyan V, Bao WL, Yoshihara K, Faden AI. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci. 2001;21:7439–46.PubMedGoogle Scholar
  32. Weissenberger CA, Sirén AL. Experimental traumatic brain injury. Exp Transl Stroke Med. 2010;2:2–16.View ArticleGoogle Scholar
  33. Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem. 1993;61:2015–24.View ArticlePubMedGoogle Scholar
  34. Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998;89:507–18.View ArticlePubMedGoogle Scholar
  35. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995;92:7162–6.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol. 2003;4:552–65.View ArticlePubMedGoogle Scholar
  37. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001;69:369–81.View ArticlePubMedGoogle Scholar
  38. Rao VL, Başkaya MK, Doğan A, Rothstein JD, Dempsey RJ. Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain. J Neurochem. 1998;70:2020–7.PubMedGoogle Scholar
  39. Allen NJ, Káradóttir R, Attwell D. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pfügers Archiv. 2004;449:132–42.View ArticleGoogle Scholar
  40. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 2004;61:657–68.View ArticlePubMedGoogle Scholar
  41. Hardingham GE. Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans. 2009;37:1147–60.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Kazanis I, Bozas E, Philippidis H, Stylianopoulo F. Neuroprotective effect of insulin-like grown factor 1 (IGF-1) following a penetrating brain injury in rats. Brain Res. 2003;991:34–45.View ArticlePubMedGoogle Scholar
  43. Sritaran K, Thompson H. Understanding the metabolic response to trauma. Br J Hosp Med (Lond). 2009;70:M156–8.View ArticleGoogle Scholar
  44. Van Dongen AM. Editor. Frontiers in Neuroscience. Biology of NMDA receptor. Duke University Medical Center, North Carolina. Boca Raton (FL): CRC Press/Taylor & Francis; 2009.Google Scholar
  45. Sihver S, Marklund N, Hillered L, Långström B, Watanabe Y, Bergström M. Changes in mACh, NMDA and GABA(A) receptor binding after lateral fluid-percussion injury: in vitro autoradiography of rat brain frozen sections. J Neurochem. 2001;78:417–23.View ArticlePubMedGoogle Scholar
  46. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E. Dynamic changes in N-methyl-d-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive déficits. Proc Natl Acad Sci U S A. 2004;101:5117–22.View ArticlePubMedPubMed CentralGoogle Scholar
  47. Park Y, Luo T, Zhang F, Liu C, Bramlett HM, Dietrich WD, Hu B. Downregulation of Src-kinase and glutamate-receptor phosphorylation after traumatic brain injury. J Cereb Blood Flow Metab. 2013;33:1642–9.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Kumar A, Zou L, Yuan X, Long Y, Yang K. N-methyl-d-aspartate receptors: transient loss of NR1/NR2A/NR2B subunits after traumatic brain injury in a rodent model. J Neurosci Res. 2002;67:781–6.View ArticlePubMedGoogle Scholar
  49. Dash MB, Douglas CL, Vyazovskiy VV, Cirelli C, Tononi G. Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. J Neurosci. 2009;29:620–9.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Muir KW. Glutamate-based therapeutic approaches: clinical trials with antagonists. Curr Opin Pharmacol. 2006;6:53–60.View ArticlePubMedGoogle Scholar
  51. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010;31:596–604.View ArticlePubMedPubMed CentralGoogle Scholar
  52. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383–6.View ArticlePubMedGoogle Scholar

Copyright

Advertisement